Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia

J. H. Caldwell, J. R. Revenaugh, G. V. Martin, P. M. Johnson, J. S. Rasey, Kenneth Krohn

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Fluorine-18-fluoromisonidazole (FMISO) is trapped in hypoxic but viable canine myocardium. Because of the potential for its use as a marker of myocardial viability, we compared FMISO activity to [18F]fluorodeoxyglucose (FDG) activity in the same myocardial samples from eight dogs subjected to 3 hr of moderate regional myocardial ischemia. Methods: Tritiated FMISO was injected 15-30 min after onset of regional ischemia (40%70% reduction in systolic well thickening) which was maintained for 3 hr. FDG was injected after 2 hr of ischemia. Myocardial blood flow (MBF) was measured by the radiolabeled microsphere technique at the time of each radiotracer injection. At 3 hr of ischemia, the heart was excised and cut into short-axis slices. One slice encompassing both ischemic and normal tissue was cut into 64 samples. FMISO and FDG activity in each sample were normalized to the mean normal zone activity and further expressed as a function of regional MBF. Results: FMISO uptake was consistently greater than FDG uptake, although this was significantly different only for MBF, between 40%-60% of normal. When analyzed relative to endocardial-epicardial location, endocardial FMISO uptake was significantly greater in all hypoperfused samples. Conclusion: These results suggest that FMISO is as sensitive as FDG for detecting myocardial ischemia and could be used for identification of viable myocardium.

Original languageEnglish (US)
Pages (from-to)1633-1638
Number of pages6
JournalJournal of Nuclear Medicine
Volume36
Issue number9
StatePublished - 1995
Externally publishedYes

Fingerprint

Fluorodeoxyglucose F18
Ischemia
Myocardial Ischemia
Myocardium
Fluorine
Regional Blood Flow
fluoromisonidazole
Microspheres
Canidae
Dogs
Injections

Keywords

  • fluorine-18-fluorodeoxyglucose
  • fluorine-18-fluoromisonidazole
  • myocardial blood flow
  • myocardial viability

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Caldwell, J. H., Revenaugh, J. R., Martin, G. V., Johnson, P. M., Rasey, J. S., & Krohn, K. (1995). Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia. Journal of Nuclear Medicine, 36(9), 1633-1638.

Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia. / Caldwell, J. H.; Revenaugh, J. R.; Martin, G. V.; Johnson, P. M.; Rasey, J. S.; Krohn, Kenneth.

In: Journal of Nuclear Medicine, Vol. 36, No. 9, 1995, p. 1633-1638.

Research output: Contribution to journalArticle

Caldwell, JH, Revenaugh, JR, Martin, GV, Johnson, PM, Rasey, JS & Krohn, K 1995, 'Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia', Journal of Nuclear Medicine, vol. 36, no. 9, pp. 1633-1638.
Caldwell, J. H. ; Revenaugh, J. R. ; Martin, G. V. ; Johnson, P. M. ; Rasey, J. S. ; Krohn, Kenneth. / Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia. In: Journal of Nuclear Medicine. 1995 ; Vol. 36, No. 9. pp. 1633-1638.
@article{f549a14c28ec4a689780a7e159d02c81,
title = "Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia",
abstract = "Fluorine-18-fluoromisonidazole (FMISO) is trapped in hypoxic but viable canine myocardium. Because of the potential for its use as a marker of myocardial viability, we compared FMISO activity to [18F]fluorodeoxyglucose (FDG) activity in the same myocardial samples from eight dogs subjected to 3 hr of moderate regional myocardial ischemia. Methods: Tritiated FMISO was injected 15-30 min after onset of regional ischemia (40{\%}70{\%} reduction in systolic well thickening) which was maintained for 3 hr. FDG was injected after 2 hr of ischemia. Myocardial blood flow (MBF) was measured by the radiolabeled microsphere technique at the time of each radiotracer injection. At 3 hr of ischemia, the heart was excised and cut into short-axis slices. One slice encompassing both ischemic and normal tissue was cut into 64 samples. FMISO and FDG activity in each sample were normalized to the mean normal zone activity and further expressed as a function of regional MBF. Results: FMISO uptake was consistently greater than FDG uptake, although this was significantly different only for MBF, between 40{\%}-60{\%} of normal. When analyzed relative to endocardial-epicardial location, endocardial FMISO uptake was significantly greater in all hypoperfused samples. Conclusion: These results suggest that FMISO is as sensitive as FDG for detecting myocardial ischemia and could be used for identification of viable myocardium.",
keywords = "fluorine-18-fluorodeoxyglucose, fluorine-18-fluoromisonidazole, myocardial blood flow, myocardial viability",
author = "Caldwell, {J. H.} and Revenaugh, {J. R.} and Martin, {G. V.} and Johnson, {P. M.} and Rasey, {J. S.} and Kenneth Krohn",
year = "1995",
language = "English (US)",
volume = "36",
pages = "1633--1638",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "9",

}

TY - JOUR

T1 - Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia

AU - Caldwell, J. H.

AU - Revenaugh, J. R.

AU - Martin, G. V.

AU - Johnson, P. M.

AU - Rasey, J. S.

AU - Krohn, Kenneth

PY - 1995

Y1 - 1995

N2 - Fluorine-18-fluoromisonidazole (FMISO) is trapped in hypoxic but viable canine myocardium. Because of the potential for its use as a marker of myocardial viability, we compared FMISO activity to [18F]fluorodeoxyglucose (FDG) activity in the same myocardial samples from eight dogs subjected to 3 hr of moderate regional myocardial ischemia. Methods: Tritiated FMISO was injected 15-30 min after onset of regional ischemia (40%70% reduction in systolic well thickening) which was maintained for 3 hr. FDG was injected after 2 hr of ischemia. Myocardial blood flow (MBF) was measured by the radiolabeled microsphere technique at the time of each radiotracer injection. At 3 hr of ischemia, the heart was excised and cut into short-axis slices. One slice encompassing both ischemic and normal tissue was cut into 64 samples. FMISO and FDG activity in each sample were normalized to the mean normal zone activity and further expressed as a function of regional MBF. Results: FMISO uptake was consistently greater than FDG uptake, although this was significantly different only for MBF, between 40%-60% of normal. When analyzed relative to endocardial-epicardial location, endocardial FMISO uptake was significantly greater in all hypoperfused samples. Conclusion: These results suggest that FMISO is as sensitive as FDG for detecting myocardial ischemia and could be used for identification of viable myocardium.

AB - Fluorine-18-fluoromisonidazole (FMISO) is trapped in hypoxic but viable canine myocardium. Because of the potential for its use as a marker of myocardial viability, we compared FMISO activity to [18F]fluorodeoxyglucose (FDG) activity in the same myocardial samples from eight dogs subjected to 3 hr of moderate regional myocardial ischemia. Methods: Tritiated FMISO was injected 15-30 min after onset of regional ischemia (40%70% reduction in systolic well thickening) which was maintained for 3 hr. FDG was injected after 2 hr of ischemia. Myocardial blood flow (MBF) was measured by the radiolabeled microsphere technique at the time of each radiotracer injection. At 3 hr of ischemia, the heart was excised and cut into short-axis slices. One slice encompassing both ischemic and normal tissue was cut into 64 samples. FMISO and FDG activity in each sample were normalized to the mean normal zone activity and further expressed as a function of regional MBF. Results: FMISO uptake was consistently greater than FDG uptake, although this was significantly different only for MBF, between 40%-60% of normal. When analyzed relative to endocardial-epicardial location, endocardial FMISO uptake was significantly greater in all hypoperfused samples. Conclusion: These results suggest that FMISO is as sensitive as FDG for detecting myocardial ischemia and could be used for identification of viable myocardium.

KW - fluorine-18-fluorodeoxyglucose

KW - fluorine-18-fluoromisonidazole

KW - myocardial blood flow

KW - myocardial viability

UR - http://www.scopus.com/inward/record.url?scp=0029119230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029119230&partnerID=8YFLogxK

M3 - Article

C2 - 7658224

AN - SCOPUS:0029119230

VL - 36

SP - 1633

EP - 1638

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 9

ER -